CommercialAdministrativeLow impact
11.08.17l, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toenails
Independence Blue Cross·Podiatry, Dermatology, Family Medicine·Medical Policy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
This is a reissue of the existing policy for debridement of mycotic and symptomatic non-mycotic hypertrophic toenails. The policy has been reposted with an effective date of April 1, 2026, but no substantive changes to coverage or billing requirements are indicated.
Action Required
By April 1, 2026: Billing team should review the full policy text at the provided URL to confirm any potential changes to coverage criteria or documentation requirements for toenail debridement procedures. No immediate action required as this appears to be a policy reissue.